P3 Health Partners Ratios (2019-2025) | PIII

Ratios Dec2019 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter)
82.34%-4.01%-3.29%258.96%99.68%0.74%-2.63%-308.13%5.46%99.74%3.17%-6.00%99.92%3.69%99.96%-320.44%0.32%1.25%99.93%99.91%
EBT Margin (Quarter)
-1,610.98%-20.38%-20.52%258.96%-22.22%-335.16%-26.31%-205.44%-17.27%-8.31%-12.79%-19.41%-12.24%-7.33%-29.40%-33.50%-11.57%-11.72%-20.12%-43.33%
EBIT Margin (Quarter)
-848.83%-17.96%-18.01%258.96%-19.07%-338.53%-24.17%-207.79%-16.16%-6.39%-11.73%-18.53%-11.28%-8.26%-29.55%-37.36%-10.21%-9.59%-12.81%-39.98%
EBITDA Margin (Quarter)
-827.09%-17.96%-18.01%258.96%-18.85%-338.31%-23.89%-207.56%-15.96%-6.21%-11.56%-18.38%-11.15%-8.11%-29.38%-37.18%-10.04%-9.42%-12.66%-39.85%
Operating Margin (Quarter)
-848.83%-17.96%-18.01%258.96%-19.07%-338.53%-24.17%-207.79%-16.16%-6.39%-11.73%-18.53%-11.28%-8.26%-29.55%-37.36%-10.21%-9.59%-12.81%-39.98%
Net Margin (Quarter)
-1,610.98%-20.38%-20.52%258.96%-3.87%-335.16%-26.31%-206.16%-17.36%-8.38%-12.93%-19.92%-12.77%-7.59%-28.40%-34.84%-11.86%-12.27%-20.12%-43.06%
FCF Margin (Quarter)
-900.42%-15.38%-4.36%-10.47%-17.01%-8.80%-12.36%-8.01%-9.13%-2.77%-4.52%-5.16%-2.70%-6.25%-15.44%-8.97%-4.67%-4.46%-6.63%
Efficiency
Assets Average (Quarter)
100.31M205.63M316.85M1,900.43M1,413.67M1,129.85M872.00M888.19M902.93M878.93M858.45M874.34M863.05M808.38M783.64M757.73M707.57M670.10M
Equity Average (Quarter)
-142.31M-168.86M-199.16M-243.96M-4.97M185.80M93.35M41.97M1.58M-69.43M25.89M165.04M144.36M156.72M143.68M98.22M69.59M53.85M12.89M-86.94M
Invested Capital (Quarter)
-154.41M-183.31M-215.01M-272.92M265.37M109.80M78.08M100.28M105.44M-27.98M296.19M250.45M264.72M299.96M253.74M184.84M234.37M226.41M234.11M73.17M
Asset Utilization Ratio (Quarter)
0.480.710.931.241.281.301.441.581.601.711.861.901.932.042.18
Leverage & Solvency
Debt to Equity (Quarter)
0.310.751.0216.13-40.27-0.790.580.760.820.801.112.422.712.30-11.47-1.76
Debt Ratio (Quarter)
0.030.060.060.110.120.120.120.130.140.150.160.230.220.140.310.42
Equity Ratio (Quarter)
-1.64-0.58-0.680.110.080.060.010.00-0.150.210.170.170.190.140.100.080.06-0.03-0.24
Valuation
Enterprise Value (Quarter)
-26.03M-16.55M-4.68M-5.36M1,641.41M943.18M938.72M498.38M465.33M601.74M255.65M250.61M206.53M119.78M75.30M29.49M16.52M3.37M-0.85M-10.80M
Return Ratios
Return on Sales (Quarter)
-0.16%0.00%0.00%0.03%0.00%-0.03%0.00%-0.02%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Capital Employed (Quarter)
-25.61%-38.77%-175.74%-258.59%-104.49%-100.72%-28.98%-31.05%-33.18%-53.83%-102.79%-113.85%-125.71%-89.89%-216.51%
Return on Invested Capital (Quarter)
-0.18%-0.15%-0.17%-0.05%-0.01%-0.01%-0.01%-0.01%-0.01%-0.02%-0.01%-0.01%-0.02%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%-0.01%-0.02%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter)
0.00%0.00%-0.02%-0.89%-0.02%-0.05%-0.37%-9.80%0.10%-0.25%-0.01%-0.01%-0.01%-0.02%-0.03%-0.04%-0.06%-0.22%0.04%